| First Author | Djaziri N | Year | 2023 |
| Journal | PLoS One | Volume | 18 |
| Issue | 12 | Pages | e0294922 |
| PubMed ID | 38039285 | Mgi Jnum | J:359682 |
| Mgi Id | MGI:7564875 | Doi | 10.1371/journal.pone.0294922 |
| Citation | Djaziri N, et al. (2023) Cleavage of periostin by MMP9 protects mice from kidney cystic disease. PLoS One 18(12):e0294922 |
| abstractText | The matrix metalloproteinase MMP9 influences cellular morphology and function, and plays important roles in organogenesis and disease. It exerts both protective and deleterious effects in renal pathology, depending upon its specific substrates. To explore new functions for MMP9 in kidney cysts formation and disease progression, we generated a mouse model by breeding juvenile cystic kidney (jck) mice with MMP9 deficient mice. Specifically, we provide evidence that MMP9 is overexpressed in cystic tissue where its enzymatic activity is increased 7-fold. MMP9 deficiency in cystic kidney worsen cystic kidney diseases by decreasing renal function, favoring cyst expansion and fibrosis. In addition, we find that periostin is a new critical substrate for MMP9 and in its absence periostin accumulates in cystic lining cells. As periostin promotes renal cyst growth and interstitial fibrosis in polycystic kidney diseases, we propose that the control of periostin by MMP9 and its associated intracellular signaling pathways including integrins, integrin-linked kinase and focal adhesion kinase confers to MMP9 a protective effect on the severity of the disease. |
